Chewing capacity and ideal cardiovascular health in adulthood: A cross-sectional analysis of a population-based cohort study.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
05 2020
Historique:
received: 17 04 2019
revised: 24 05 2019
accepted: 30 05 2019
pubmed: 27 6 2019
medline: 18 8 2021
entrez: 26 6 2019
Statut: ppublish

Résumé

To study the association between chewing capacity-a prerequisite for eating- and the level of cardiovascular health (CVH). This is a cross-sectional analysis conducted on 5430 study participants from the Paris Prospective Study 3 that were subjected to an oral examination by trained dentists at study recruitment between 2008 and 2012. Chewing capacity was determined by the number of functional tooth units (FTUs), and ≥ 5FTUs defined adequate chewing capacity. Subjects were categorized into poor, intermediate, or ideal CVH for the 4 behavioural (smoking status, body mass index, physical activity, diet) and the 3 biological (total cholesterol, fasting glycemia, and blood pressure) factors according to the American Heart Association Life's Simple 7. Multinomial logistic regression was used to explore the association between the number of FTUs (exposure) and ideal or intermediate vs. poor CVH (main outcome). 10.31% of the study participants had an ideal CVH and 7% presented an impaired chewing capacity (<5 FTUs). Subjects with at least 5 FTUs (OR = 2.37; 95% CI: 1.37-4.12) were more likely to have an ideal global CVH, after adjustment for age, sex, marital status, education, deprivation, depressive status, and dental plaque. This association existed for the behavioural but not the biological CVH, with the strongest association being observed with the diet metric. This is the first study suggesting that adults with a preserved chewing capacity have an increased likelihood to be at an ideal behavioural CVH.

Sections du résumé

BACKGROUND AND AIMS
To study the association between chewing capacity-a prerequisite for eating- and the level of cardiovascular health (CVH).
METHODS
This is a cross-sectional analysis conducted on 5430 study participants from the Paris Prospective Study 3 that were subjected to an oral examination by trained dentists at study recruitment between 2008 and 2012. Chewing capacity was determined by the number of functional tooth units (FTUs), and ≥ 5FTUs defined adequate chewing capacity. Subjects were categorized into poor, intermediate, or ideal CVH for the 4 behavioural (smoking status, body mass index, physical activity, diet) and the 3 biological (total cholesterol, fasting glycemia, and blood pressure) factors according to the American Heart Association Life's Simple 7. Multinomial logistic regression was used to explore the association between the number of FTUs (exposure) and ideal or intermediate vs. poor CVH (main outcome).
RESULTS
10.31% of the study participants had an ideal CVH and 7% presented an impaired chewing capacity (<5 FTUs). Subjects with at least 5 FTUs (OR = 2.37; 95% CI: 1.37-4.12) were more likely to have an ideal global CVH, after adjustment for age, sex, marital status, education, deprivation, depressive status, and dental plaque. This association existed for the behavioural but not the biological CVH, with the strongest association being observed with the diet metric.
CONCLUSION
This is the first study suggesting that adults with a preserved chewing capacity have an increased likelihood to be at an ideal behavioural CVH.

Identifiants

pubmed: 31235417
pii: S0261-5614(19)30257-2
doi: 10.1016/j.clnu.2019.05.029
pii:
doi:

Substances chimiques

Blood Glucose 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1440-1446

Informations de copyright

Copyright © 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Auteurs

Hélène Rangé (H)

Department of Periodontology, Service of Odontology, Rothschild Hospital, AP-HP, Faculty of Odontology, University of Paris, 5 rue Garancière, 75006 Paris, France; EA 2496, Laboratory of Orofacial Pathologies, Imaging and Biotherapies, School of Dentistry, University of Paris, 1 rue Maurice Arnoux, 92120 Montrouge, France. Electronic address: helene.range@gmail.com.

Marie-Cécile Perier (MC)

INSERM U970, Paris Cardiovascular Research Centre (PARCC), University of Paris, 56 rue Leblanc, 75015 Paris, France; INSERM U970, Paris Cardiovascular Research Centre (PARCC), Integrative Epidemiology of Cardiovascular Disease (Team 4), 56 rue Leblanc, 75015 Paris, France.

Adrien Boillot (A)

Department of Periodontology, Service of Odontology, Rothschild Hospital, AP-HP, Faculty of Odontology, University of Paris, 5 rue Garancière, 75006 Paris, France.

Lucile Offredo (L)

INSERM U970, Paris Cardiovascular Research Centre (PARCC), University of Paris, 56 rue Leblanc, 75015 Paris, France; INSERM U970, Paris Cardiovascular Research Centre (PARCC), Integrative Epidemiology of Cardiovascular Disease (Team 4), 56 rue Leblanc, 75015 Paris, France.

Quentin Lisan (Q)

INSERM U970, Paris Cardiovascular Research Centre (PARCC), University of Paris, 56 rue Leblanc, 75015 Paris, France; INSERM U970, Paris Cardiovascular Research Centre (PARCC), Integrative Epidemiology of Cardiovascular Disease (Team 4), 56 rue Leblanc, 75015 Paris, France; Department of Head and Neck Surgery, Georges Pompidou European Hospital, 20 Rue Leblanc, 75015 Paris, France.

Catherine Guibout (C)

INSERM U970, Paris Cardiovascular Research Centre (PARCC), University of Paris, 56 rue Leblanc, 75015 Paris, France; INSERM U970, Paris Cardiovascular Research Centre (PARCC), Integrative Epidemiology of Cardiovascular Disease (Team 4), 56 rue Leblanc, 75015 Paris, France.

Frédérique Thomas (F)

Preventive and Clinical Investigation Center (IPC), 6 Rue La Perouse, 75116 Paris, France.

Nicolas Danchin (N)

Preventive and Clinical Investigation Center (IPC), 6 Rue La Perouse, 75116 Paris, France.

Pierre Boutouyrie (P)

INSERM U970, Paris Cardiovascular Research Centre (PARCC), University of Paris, 56 rue Leblanc, 75015 Paris, France; INSERM, UMR-S970, Paris Cardiovascular Research Center, Pathophysiology and Pharmacology of Large Arteries (Team 7), 56 rue Leblanc, 75015 Paris, France.

Xavier Jouven (X)

INSERM U970, Paris Cardiovascular Research Centre (PARCC), University of Paris, 56 rue Leblanc, 75015 Paris, France; INSERM U970, Paris Cardiovascular Research Centre (PARCC), Integrative Epidemiology of Cardiovascular Disease (Team 4), 56 rue Leblanc, 75015 Paris, France.

Philippe Bouchard (P)

Department of Periodontology, Service of Odontology, Rothschild Hospital, AP-HP, Faculty of Odontology, University of Paris, 5 rue Garancière, 75006 Paris, France; EA 2496, Laboratory of Orofacial Pathologies, Imaging and Biotherapies, School of Dentistry, University of Paris, 1 rue Maurice Arnoux, 92120 Montrouge, France.

Jean-Philippe Empana (JP)

INSERM U970, Paris Cardiovascular Research Centre (PARCC), University of Paris, 56 rue Leblanc, 75015 Paris, France; INSERM U970, Paris Cardiovascular Research Centre (PARCC), Integrative Epidemiology of Cardiovascular Disease (Team 4), 56 rue Leblanc, 75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH